Esophageal Neoplasms: all 1,631 studies
Page 12 of 17. Open to participants first (469), then studies with results posted, then the rest; newest registration first within each.
- Human (Autologous) Oral Mucosal Cell Sheet Transplantation After ESD in Patients With Superficial Esophageal CancerCompletedNCT02866019Phase 3
- Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal CarcinomaCompletedNCT02861690Phase 2
- Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal CarcinomaStatus unknownNCT02858206Phase 2
- Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal CancerWithdrawnNCT02857218Early Phase 1
- Different Radiation Dose With Concurrent Chemotherapy for Thoracic Esophageal CarcinomaCompletedNCT02850991Not applicable
- Effects of a "Walk, Eat, & Breathe" Nursing Intervention For Patients With Esophageal CancerStatus unknownNCT02850172Not applicable
- The Thoracic Peri-Operative Integrative Surgical Care Evaluation (POISE) Trial- Stage ICompletedNCT02845479Phase 3
- Study of Inspiratory Muscle Training for Patients Undergoing Esophageal SurgeryWithdrawnNCT02843750Not applicable
- Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal CancerCompletedNCT02843581Phase 1/2
- PET-CT vs DWI-MRI in Response Evaluation in Esophageal CancerCompletedNCT02839109
- S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal CancerCompletedNCT02813967Phase 3
- Tumour and HEalthy Tissues DOse-response and Radiosensitivity AssayTerminatedNCT02797405Not applicable
- A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal CancerStatus unknownNCT02773524Phase 3
- Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal CancerStatus unknownNCT02762474Phase 1/2
- CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal TumorsTerminatedNCT02757391Phase 1
- Itraconazole as a Targeted Therapy for Inhibiting Hedgehog Pathway Signaling in Esophageal Cancer PatientsStatus unknownNCT02749513Early Phase 1
- Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients.Status unknownNCT02745561Phase 2
- 99mTc-3PRGD2 SPECT/CT in Esophagus Cancer PatientsCompletedNCT02744729Early Phase 1
- Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose EscalationStatus unknownNCT02741856Phase 2/3
- A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCCTerminatedNCT02721576Phase 4
- A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCCCompletedNCT02721563Phase 4
- A Trial of CMNa Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced ESCCTerminatedNCT02721550Phase 4
- S-1 and Radiotherapy for Elderly Esophageal Cancer PatientsWithdrawnNCT02716688Phase 2
- Endoscopic Evaluation After EsophagectomyCompletedNCT02703142
- A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or CholangiocarcinomaCompletedNCT02699606Phase 2
- DC Vaccine Combined With CIK Cells in Patients With Esophagus CancerStatus unknownNCT02693236Phase 1/2
- MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal CancerWithdrawnNCT02689401Phase 1
- Study of Apatinib in Metastatic Esophageal CancerStatus unknownNCT02683655Phase 2
- Influence of Esophageal Washout on Local Carcinoma Recurrence After Curative ResectionCompletedNCT02676791Not applicable
- The Clinical Physics Research of Image Guided Adaptive Radiation Therapy for Esophagus CancerStatus unknownNCT02653521Not applicable
- Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal CancerStatus unknownNCT02644863Phase 2
- Megestrol Acetate for the Improvement of Quality of Life in Esophageal Cancer With ChemoradiotherapyCompletedNCT02644408Phase 3
- Definitive Chemoradiotherapy and Cetuximab in the Treatment of Locally Advanced Esophageal CancerStatus unknownNCT02636088Phase 2
- Research on the Role of SLC1A5 in the Development of Esophageal CancerStatus unknownNCT02633436
- Ramucirumab/Paclitaxel as Second-line Treatment in Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma With Integrative Genomic AnalysisCompletedNCT02628951Phase 2
- Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac CancerStatus unknownNCT02628665Phase 3
- Pilot Sudy: Resectable Esophageal Adenocarcinoma and the Relevance of CTCCompletedNCT02610764Not applicable
- CCRT for Esophageal Cancer.CompletedNCT02607982Phase 2
- Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid TumorsStatus unknownNCT02607826Not applicable
- The Role of Different Cycles of Chemotherapy（Capecitabine-oxaliplatin） in Esophageal ChemoradiotherapyStatus unknownNCT02604615Phase 3
- Endodrill vs. Conventional Biopsy. Diagnostics and Genetic AnalysisTerminatedNCT02601079Not applicable
- Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer.WithdrawnNCT02598687Phase 1
- Nimotuzumab in Combination With Radiotherapy for Esophageal CancerCompletedNCT02591784Phase 2
- Paclitaxel or S1 Plus Cisplatin in Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of EsophagusStatus unknownNCT02586753Phase 2
- Tumor Hypoxia With HX4 PET in Several DiseasesTerminatedNCT02584400Phase 2
- ESD for the Treatment of Early Barrett's NeoplasiaStatus unknownNCT02583087
- A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell CarcinomaStatus unknownNCT02570893Phase 3
- Radiofrequency in the Treatment of Barrett's OesophagusCompletedNCT02558504Phase 4
- Simultaneous Modulated Accelerated Boost Versus Standard Dose Radiotherapy in Esophageal CancerActive, not recruitingNCT02556762Phase 3
- MR/PET in the Evaluation of Patients With Esophageal CancerStatus unknownNCT02547610
- Early Integration of Palliative Care in Esophageal Cancer PatientsTerminatedNCT02547142Not applicable
- SBRT Combined With Thymalfasin for Metastatic Esophageal CancerStatus unknownNCT02545751Phase 2
- Apatinib for Metastatic Esophageal Cancer.Status unknownNCT02544737Phase 2
- Diffusion-weighted Magnetic Resonance Imaging (DW-MRI )for Early Response Assessment in Patients With Esophageal CancerStatus unknownNCT02527057
- Placing Trust in Endoscopic Ultrasonography: Impact on Planning Conformal Radiotherapy of Cancer of the Esophagus and RectumCompletedNCT02526134Phase 2
- Adjuvant Durvalumab for Esophageal CancerStatus unknownNCT02520453Phase 2
- A Study of Donafenib Monotherapy in Advanced Oesophageal CancerTerminatedNCT02489201Phase 1/2
- Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)Active, not recruitingNCT02465736Phase 3
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Active, not recruitingNCT02465060Phase 2
- Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell CarcinomaStatus unknownNCT02461043Phase 3
- Esophagectomy With or Without Prior Ischemic Gastric PreconditioningTerminatedNCT02457299Not applicable
- Pencil Beam Scanning Proton Radiotherapy for Esophageal CancerCompletedNCT02452021
- Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic ApproachStatus unknownNCT02448979Phase 3
- Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic EsophagectomyStatus unknownNCT02448966
- Two-field Versus Three-field Lymphadenectomy in Thoracic Esophageal Carcinoma Without Cervical Lymph Node InvolvementStatus unknownNCT02448953Not applicable
- Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell CarcinomaCompletedNCT02446574Phase 1/2
- WEI NASAL JET for The Sedation of Outpatient Upper Gastrointestinal EndoscopyStatus unknownNCT02436018Not applicable
- The Role of Chromoendoscopy in the Early Detection of Esophageal Cancer in Patients With Prior Head and Neck CancersCompletedNCT02435602Not applicable
- Irreversible Electroporation(IRE) For Unresectable Esophageal NeoplasmsCompletedNCT02430701Not applicable
- Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal CarcinomaCompletedNCT02429622Phase 1/2
- Esophagectomy for Patients With Esophageal Cancer and Cervical Lymph Node MetastasesCompletedNCT02426879Not applicable
- A Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric CancerCompletedNCT02426034Phase 4
- 4D FDG PET in Esophageal CancerCompletedNCT02424864Not applicable
- Effect of Neck Flexion on Esophagogastric Anastomotic Leakage After MIEStatus unknownNCT02418052Not applicable
- Timing of Resective Surgery After Neoadjuvant Chemoradiotherapy in Esophageal CancerCompletedNCT02415101Not applicable
- Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric CarcinomaCompletedNCT02406170Phase 1/2
- Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal CancerCompletedNCT02403531Phase 2
- Feasibility Study of Fiducial Markers in Oesophageal CancerStatus unknownNCT02403050
- Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell CarcinomaCompletedNCT02395705Phase 3
- Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal CancerCompletedNCT02389751Phase 1
- Longitudinal Assessment of Gut Hormone Secretion Following Upper Gastrointestinal Surgery for CancerCompletedNCT02385630Not applicable
- Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for CancerCompletedNCT02385617Not applicable
- The Predictive Value of CT-PET in Esophageal CancerCompletedNCT02385604
- Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation TherapyActive, not recruitingNCT02381561Phase 1
- The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal SurgeryCompletedNCT02381249Not applicable
- Nutritional Route In Esophageal Resection Trial IICompletedNCT02378948Not applicable
- PCA062 in pCAD-positive Tumors.CompletedNCT02375958Phase 1
- Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal CancerStatus unknownNCT02375581Phase 2
- Relationship Between Endoscopic Ultrasound Staging and Degree of Stricture in Esophageal CancerCompletedNCT02372929
- PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional CancerCompletedNCT02359968Phase 2
- Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal CancerStatus unknownNCT02355249Phase 3
- A Phase II Trial of Afatinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of EsophagusStatus unknownNCT02353936Phase 2
- Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal CancerCompletedNCT02350517Phase 2
- Feasibility Study of Adjuvant Treatment With S-1 and Oxaliplatin in Patients With Resectable Esophageal CancerCompletedNCT02347904Phase 1
- C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal CancerWithdrawnNCT02344810Phase 1/2
- Effects of a Training Intervention After Thoracoabdominal Oesophagus SurgeryCompletedNCT02335970Not applicable
- Cardiopulmonary Effects of Intrathoracic Pressure Overshoot During Carbon Dioxide Insufflation in Thoracoscopic SurgeryCompletedNCT02330536Not applicable
- Low-dose Aspirin Therapy for Esophageal CancerWithdrawnNCT02326779Phase 3
- Defining the Radiotherapy Dose and Volume Parameters Affecting Postoperative Complications in Esophageal Cancer PatientsTerminatedNCT02323776
- Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 TrialStatus unknownNCT02319187Phase 3